[1] Malemud C J. Inhibition of MMPs and ADAM/ADAMTS[J]. Biochem Pharmacol, 2019, 165: 33- 40.
[2] Dou Y, Li C, Li L, et al. Bioresponsive drug delivery systems for the treatment of inflammatory diseases[J]. J Control Release, 2020,327: 641-666.
[3] Yu C, Liu H, Guo C, et al. Dextran sulfate-based MMP-2 enzyme-sensitive SR-A receptor targeting nanomicelles for the treatment of rheumatoid arthritis[J]. Drug Deliv, 2022, 29 (1): 454-465.
[4] Zhang M, Hu W, Cai C, et al. Advanced application of stimuli-responsive drug delivery system for inflammatory arthritis treatment[J]. Mater Today Bio, 2022, 14:100223.
[5] Municoy S, Alvarez Echazu M I, Antezana P E, et al. Stimuli-responsive materials for tissue engineering and drug delivery[J]. Int J Mol Sci,2020, 21 (13): 4724.
[6] Ding H, Tan P, Fu S, et al. Preparation and application of pH-responsive drug delivery systems[J]. J Control Release, 2022, 348: 206-238.
[7] Lin H C, Chiang H P, Jiang W P, et al. Exploitation of a rod-shaped, acid-labile curcumin-loaded polymeric nanogel system in the treatment of systemic inflammation[J]. Biomater Adv, 2022, 133: 112597.
[8] Bajpayee A G, Quadir M A, Hammond P T, et al. Charge based intra-cartilage delivery of single dose dexamethasone using Avidin nano-carriers suppresses cytokine-induced catabolism long term[J]. Osteoarthritis Cartilage, 2016, 24 (1): 71-81.
[9] Mathiyalagan R, Wang C, Kim Y J, et al. Preparation of polyethylene glycol-ginsenoside Rh1 and Rh2 conjugates and their efficacy against lung cancer and inflammation[J] . Molecules, 2019, 24 (23):221-227.
[10] Nash K M and Ahmed S. Nanomedicine in the ROS-mediated pathophysiology: Applications and clinical advances[J]. Nanomedicine, 2015, 11 (8): 2033-2040.
[11] Chen X, Li C, Cao X, et al. Mitochondria-targeted supramolecular coordination container encapsulated with exogenous itaconate for synergistic therapy of joint inflammation[J]. Theranostics, 2022, 12 (7): 3251-3272.
[12] Bai S, Ma X, Shi X, et al. Smart unimolecular micelle-based polyprodrug with dual-redox stimuli response for tumor microenvironment: enhanced in vivo delivery efficiency and tumor penetration[J]. ACS Appl Mater Interfaces, 2019, 11 (39): 36130-36140.
[13] Xue S, Zhou X, Sang W, et al. Cartilage-targeting peptide-modified dual-drug delivery nanoplatform with NIR laser response for osteoarthritis therapy[J]. Bioact Mater, 2021, 6 (8): 2372-2389.
[14] Krishnan Y, Rees H A, Rossitto C P, et al. Green fluorescent proteins engineered for cartilage-targeted drug delivery: insights for transport into highly charged avascular tissues[J]. Biomaterials, 2018, 183: 218-233.
[15] Luo J, Zhang Y, Zhu S, et al. The application prospect of metal/metal oxide nanoparticles in the treatment of osteoarthritis[J]. Naunyn Schmiedebergs Arch Pharmacol, 2021, 394 (10): 1991-2002.
[16] Zhang S, Wu L, Cao J, et al. Effect of magnetic nanoparticles size on rheumatoid arthritis targeting and photothermal therapy[J]. Colloids Surf B Biointerfaces, 2018, 170: 224-232.
[17] Rehman M, Ihsan A, Madni A, et al. Solid lipid nanoparticles for thermoresponsive targeting: evidence from spectrophotometry, electrochemical, and cytotoxicity studies[J]. Int J Nanomedicine, 2017, 12: 8325-8336.
[18] Chen Z P, Liu W, Liu D, et al. Development of brucine-loaded microsphere/thermally responsive hydrogel combination system for intra-articular administration[J]. J Control Release, 2012, 162 (3): 628-635.
[19] Betre H, Liu W, Zalutsky M R, et al. A thermally responsive biopolymer for intra-articular drug delivery[J]. J Control Release, 2006, 115 (2): 175-182.
[20] Zhao W, Wang H, Wang H, et al. Light-responsive dual-functional biodegradable mesoporous silica nanoparticles with drug delivery and lubrication enhancement for the treatment of osteoarthritis[J]. Nanoscale, 2021, 13 (13): 6394-6399.
[21] Lee S, Kim H, Ha Y, et al. Targeted chemo-photothermal treatments of rheumatoid arthritis using gold half-shell multifunctional nanoparticles[J]. ACS Nano, 2013, 7 (1): 50-57.
[22] Wu H, He Y, Wu H, et al. Near-infrared fluorescence imaging-guided focused ultrasound-mediated therapy against rheumatoid arthritis by MTX-ICG-loaded iRGD-modified echogenic liposomes[J]. Theranostics, 2020, 10 (22): 10092-10105.
[23] Wang L, Zhu B, Huang J, et al. Ultrasound-targeted microbubble destruction augmented synergistic therapy of rheumatoid arthritis via targeted liposomes[J]. J Mater Chem B, 2020,8 (24): 5245-5256.
[24] Nele V, Schutt C E, Wojciechowski J P, et al. Ultrasound-triggered enzymatic gelation[J]. Adv Mater, 2020, 32 (7): e1905914.
[25] Duan J, Dong J, Zhang T, et al. Polyethyleneimine-functionalized iron oxide nanoparticles for systemic siRNA delivery in experimental arthritis[J]. Nanomedicine, 2014, 9 (6): 789-801.
[26] Carneiro M F H, Machado A R T, Antunes L M G, et al. Gold-coated superparamagnetic iron oxide nanoparticles attenuate collagen-induced arthritis after magnetic targeting[J]. Biol Trace Elem Res, 2020, 194 (2): 502-513.
[27] Butoescu N, Seemayer C A, Palmer G, et al. Magnetically retainable microparticles for drug delivery to the joint: efficacy studies in an antigen-induced arthritis model in mice[J] . Arthritis Res Ther, 2009, 11 (3): R72.
[28] He X, Chen H, Chang S, et al. Multifunctional nanoparticles co-loaded with perfluoropropane, indocyanine green, and methotrexate for enhanced multimodal imaging of collagen-induced arthritis[J]. Mol Pharm, 2022, 19 (7): 2418-2428.